 |
 |
|
|
|
| Balofloxacin |
 |
| C20H24FN3O4 |
 |
| 127294 -70-6 |
 |
(Including methicillin-resistant Staphylococcus aureus MRSA) used for the treatment of the case by Staphylococcus, Streptococcus, Enterococcus the Morgan spp, Escherichia coli, the general Vuitton Escherichia, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Pseudomonas spp, Peptostreptococcus strains caused by uncomplicated urinary tract infections, such as cystitis, urethritis.
|
 |
Balofloxacin
Aliases: 1 - ring-propyl-7 - (3 - methylamino-1 - piperidine-yl) -8 - methoxy - 6 - fluoro -1,4 - dihydro -4 - oxo -3 - quinolinecarboxamide acid
MF: C20H24FN3O4
Molecular Weight: 389.42
CAS Registry Number :127294 -70-6
Description:film-coated tablets, coating removal was almost white to pale yellow.
Indications
(Including methicillin-resistant Staphylococcus aureus MRSA) used for the treatment of the case by Staphylococcus, Streptococcus, Enterococcus the Morgan spp, Escherichia coli, the general Vuitton Escherichia, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus, Pseudomonas spp, Peptostreptococcus strains caused by uncomplicated urinary tract infections, such as cystitis, urethritis.
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
